NCT05263713 - Clinical Trial References

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

Citation(s)

Alam M, Posten W, Martini MC, Wrone DA, Rademaker AW
Aesthetic and functional efficacy of subcuticular running epidermal closures of the trunk and extremity: a rater-blinded randomized control trial. Arch Dermatol. 2006 Oct;142(10):1272-8. doi: 10.1001/archderm.142.10.1272.
Moody BR, McCarthy JE, Linder J, Hruza GJ
Enhanced cosmetic outcome with running horizontal mattress sutures. Dermatol Surg. 2005 Oct;31(10):1313-6. doi: 10.1111/j.1524-4725.2005.31209.
Robinson, J
Surgery of the Skin. New York, NY: Elsevier. 2014.

Aesthetic Outcome of Running Subcuticular Suture Versus Running Horizontal Mattress Suture Closure of Linear Wounds on the Trunk and Extremities: a Randomized Evaluator Blinded Split Wound Comparative Effectiveness Trial

Details for clinical trial NCT05263713

Clinical trial NCT05263713 - References